The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

A new fund is providing up to $5,000 to Boston families who have an immediate family member who died from an opioid overdose.

Gibson called for more funds to be allocated for mobile units to care for drug users in the Bronx; Naloxone training for residents and caregivers; and an ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

The new drug type targets pathways in the peripheral nervous system before pain signals reach the brain, potentially lowering ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

See below for access to detailed information about Purdue tuition, rates and fees for online students, including fall/spring and summer rate information and other case-specific fees that may not be ...

See below for access to detailed information regarding Purdue tuition, rates and fees for undergraduate students, including summer, fall/spring and winter rate information as well as other ...

Bonus Mar 07, 2000 Apr 01, 2000 Feb 22, 2000 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Oct 26, 1998 Nov 19, 1998 Oct 08, 1998 Bonus Ratio: 1 share(s) for every 1 shares held Aurobindo ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 20,809.88 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...